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Abstract: Ampicillin has been widely used to treat bacterial infections. When we used ampicillin to eliminate bacterial contamination
in yeast cultures, we observed induction of phosphorylation of MAP kinase 1 (Mpk1), a previously unknown function of ampicillin.
We therefore investigated whether ampicillin activates the signal transduction pathway. Phosphorylation of Saccharomyces cerevisiae
Mpk1 was induced by ampicillin in a dose- and time-dependent manner through the PKC1-CWI pathway. Mpk1 phosphorylation was
maximal after treatment with 3 mM ampicillin for 90 min. Despite activation of Mpk1 phosphorylation, ampicillin did not influence
yeast cell growth. Ampicillin reduced miconazole antifungal activity; miconazole had a minimum inhibitory concentration of 3.125 µg/
mL against Candida albicans, which increased to 25 µg/mL after 48 h of treatment with 3 mM ampicillin. Finally, ampicillin activated
phosphorylation of ERK1/2 (a mammalian homolog of Mpk1), with maximum effect at 3 mM ampicillin, in human HepG2 cells, but
did not influence cell viability. The results of this study clearly indicate that ampicillin activated Mpk1 phosphorylation in yeast and
ERK1/2 phosphorylation in HepG2 cells. In addition to its clinical application to eliminate bacteria, ampicillin could also be used to
activate Mpk1 or ERK1/2 in the laboratory.
Key words: Ampicillin, CWI pathway, Mpk1, Saccharomyces cerevisiae, ERK1/2, HepG2, Candida albicans

1. Introduction
Ampicillin is a broad-spectrum antibiotic compound that
is used for the treatment of many bacterial infections.
It is relatively nontoxic and effective against many
gram-positive and gram-negative bacteria, including
Streptococcus pneumoniae, Streptococcus pyogenes,
Escherichia coli, Salmonella, and Neisseria meningitidis.
Ampicillin belongs to the family of beta-lactam antibiotics
that irreversibly inhibit the transpeptidase activity required
for the synthesis of bacteria cell walls (Acred et al., 1962;
Kennedy et al., 1963; Seligman et al., 1963; Campos et al.,
1992; Lacy et al., 1999; WHO Young Infants Study Group,
1999).
In yeast, the cell wall is the outermost component
that protects the cell and receives external signals. The
integrity and composition of the cell wall are essential for
survival and adaptation to environmental stresses. Two
pathways—the high-osmolarity glycerol (HOG1) pathway
and the cell wall integrity (CWI) pathway—are important
for maintenance of cellular integrity. Of these, the CWI
pathway is considered the most essential for recognizing
cell wall perturbations in many cell stress conditions (Levin,
* Correspondence: kiyoung@khu.ac.kr
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2005; Kim et al., 2010; Kim and Levin, 2011; Shin and
Kim, 2016). The CWI pathway is composed of cell surface
receptors (Wsc1, Wsc2 Wsc3, Mid2, and Mtl1), transducer
proteins (Rom2 and Rho1), calcium-dependent protein
kinase (Pkc1), mitogen-activated protein (MAP) kinase
kinase kinase (Bck1), MAP kinase kinases (Mkk1/2), and
MAP kinase (Mpk1). Activation of Mpk1 by signals that
are received and transmitted through the CWI pathway
activates two downstream transcription factors (Rlm1
and Swi4/6), which are involved in the regulation of the
expression of multiple cell wall components. One of the
target genes of Swi4/6 is FKS2, which encodes the catalytic
subunit of 1,3-beta-glucan synthase involved in β-glucan
biosynthesis (Kim et al., 2008, 2010; Kim and Levin, 2011).
Inhibition of the CWI pathway or mutation of involved
proteins may sensitize cells to standard antifungal drugs
(Levin, 2005; Pagán-Mercado et al., 2009; Shin and Kim,
2016).
One of the most widely used antifungal agents is
miconazole, which inhibits the cytochrome P-450dependent 14α-demethylation of lanosterol in the sterol
biosynthesis pathway (Hitchcock et al., 1990; Ghannoum
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and Rice, 1999). Azole compounds are synergistically
active with cell wall inhibitors and increase expression
of FKS2, which participates in the CWI pathway and is
also regulated by the PKC1 pathway (Cornelissen and
Van den Bossche, 1983; Lorito et al., 1994; Edlind et
al., 2002). The PKC1 pathway is associated with fungal
resistance of Candida albicans. (LaFayette et al., 2010).
Miconazole antifungal function is synergistically activated
by inhibition of Mpk1 phosphorylation (Shin and Kim,
2016), suggesting that miconazole activity is influenced by
the cell wall.
Several MAP kinase homologs have been identified,
including ERK1/2 in humans. ERK1/2 is the effector
component of the prototypical ERK1/2 MAP kinase
pathway that regulates cell proliferation, differentiation,
and survival (Davis, 1995).
When we tried to prevent bacterial contamination in
yeast cultures using ampicillin, we unexpectedly found
that ampicillin-treated controls showed elevated Mpk1
phosphorylation. Therefore, we aimed to investigate
the regulation of MAPK phosphorylation by ampicillin
in fungi and human cells. We showed that ampicillin
activated Mpk1 phosphorylation in yeast and ERK1/2
phosphorylation in HepG2 cells and reduced miconazole
antifungal activity.
2. Materials and methods
2.1. Strains and growth conditions
BY4742 Saccharomyces cerevisiae (MATα his3Δ1 leu2Δ0
lys2Δ0 ura3Δ0), Y595 bck1 deletion (MATα bck1Δ::G418),
and Y698 mpk1 deletion mutant (MATα mpk1Δ::G418)
strains from the Yeast Knockout Collection (GE
Healthcare, Aurora, OH, USA) were grown in YPD (1%
Bacto yeast extract, 2% Bacto peptone, and 2% glucose) or
SD (0.67% yeast nitrogen base and 2% glucose) medium
supplemented with the appropriate nutrients to select for
yeast strains harboring plasmids (MPK1-FLAG) at 30 °C.
Escherichia coli DH5α harboring YEp351-MPK1-FLAG
(p2313; Shin and Kim, 2016) was cultivated in Luria broth
medium (1% Bacto tryptone, 0.5% Bacto yeast extract,
and 1% NaCl) supplemented with ampicillin at 37 °C.
Ampicillin-resistant clones were used to propagate the
plasmid by standard methods. The human hepatocellular
carcinoma cell line HepG2 (Shin and Kim, 2016) was
maintained in Dulbecco’s modified Eagle’s medium
(DMEM, Invitrogen, Carlsbad, CA, USA) supplemented
with 10% (v/v) heat-inactivated fetal bovine serum, 100
g/L streptomycin, and 100 U/mL penicillin (all from
Invitrogen). The cells were cultured in a humidified
atmosphere containing 5% CO2. All chemicals, including
ampicillin (A0166), were purchased from Sigma (St. Louis,
MO, USA) or were of the highest available grade.

2.2. Immunoblot detection of phosphorylated Mpk1 in
yeast cells
Immunoblotting was performed as described by Shin
and Kim (2016) with slight modification. Y595 and Y698
strains harboring YEp351-MPK1-FLAG were grown
overnight in SD medium. Yeast cells were divided among
four or six tubes and continuously grown for 3 h at room
temperature. After 1 h of treatment with test compounds
at the indicated concentrations, cells were lysed with 200
µL of cold lysis buffer (50 mM Tris/HCl (pH 7.5), 10%
glycerol, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 50
mM NaF, 1 mM sodium orthovanadate, 50 mM β-glycerol
phosphate, 5 mM sodium pyrophosphate, 5 mM EDTA, 1
mM PMSF, and protease inhibitor cocktail (Roche, Basel,
Switzerland)) by vigorous vortexing with 0.45-mm glass
beads. Protein extracts were collected by centrifugation at
13,000 × g for 10 min at 4 °C. Protein concentrations were
determined by the Bradford assay (Bio-Rad, Hercules,
CA, USA) according to the manufacturer’s protocol.
Protein samples (20 µg for Mpk1-FLAG detection and 30
µg for phosphorylated Mpk1 detection) were separated
on 7.5% polyacrylamide SDS-PAGE gels and transferred
to nitrocellulose membranes (Amersham Hybond, GE
Healthcare). Total Mpk1 was detected with anti-FLAG
antibodies (dilution 1:4000; Cell Signaling Technology,
Danvers, MA, USA) in the presence of 5% nonfat milk for 1
h followed by horseradish peroxide-conjugated antimouse
secondary antibodies (dilution 1:4000; antimouse IgG,
HRP-linked antibody; Cell Signaling Technology) for 1
h. After stringently washing the membrane, an enhanced
chemiluminescence (ECL) detection system (Santa
Cruz Biotechnology, Houston, TX, USA) was used to
detect signals. Phosphorylation of Mpk1 was detected
by incubation with rabbit polyclonal anti-phospho-p44/
p42 MAPK (Thr202/Tyr204) antibodies (New England
Biolabs, Ipswich, MA, USA) at a dilution of 1:3000 as
described previously (Kim et al., 2008; Shin and Kim,
2016) overnight, followed by incubation with horseradish
peroxide-conjugated secondary antibodies (donkey
antirabbit antibody; GE Healthcare) at a dilution of 1:4000
for 1 h. Signals were detected using an ECL kit (Bio-Rad).
Experiments were performed at least three times, and a
representative image was selected. Densitometry analysis
of the bands was performed with ImageJ software (NIH,
Bethesda, MD, USA). In detail, the blots were scanned
and capture at 1200 dpi. Band intensities were quantified
using ImageJ (NIH). Pictures were divided by base images
of blank membranes with the same exposure length to
eliminate the background. Pictures were then inverted,
and using the gel analysis features, band intensities were
measured by selecting the band with the rectangle tool,
graphing the intensity, and calculating the area of the
intensity plots. Intensities of the selected bands from three
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different experiments were then displayed in Excel and
statistical analyses were carried out.
2.3. Immunoblot detection of phosphorylated ERK1/2 in
HepG2 cells
HepG2 cells were plated at 1 × 106 cells per 60-mm culture
dish. Before ampicillin treatment, the medium was replaced
with fresh medium without antibiotics. After treatment
with the indicated concentrations of ampicillin, cells were
washed with cold PBS and lysed using lysis buffer (20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
β-glycerol phosphate, 1 mM sodium orthovanadate, 1 µg/
mL leupeptin) containing 1 mM PMSF. Total proteins
were collected by centrifugation at 13,000 × g for 10 min at
4 °C and protein concentration was determined using the
Bradford assay (Bio-Rad). Protein samples (50 µg for total
ERK1/2 detection and 100 µg for phosphorylated ERK1/2
detection) were separated on 10% polyacrylamide SDSPAGE gels and transferred to nitrocellulose membranes
(Amersham Hybond). Membranes were incubated
with anti-ERK1 (Cell Signaling Technology) or antiphospho-p44/p42 MAPK (Thr202/Tyr204) antibodies (New
England Biolabs) at a dilution of 1:3000 overnight and
then with HRP-conjugated secondary antibodies (donkey
antirabbit antibody; GE Healthcare) at a dilution of 1:4000
for 1 h. Proteins were detected using an ECL kit (Bio-Rad).
Experiments were performed at least three times, and a
representative image was selected. Densitometry analysis
of the bands was performed with ImageJ software (NIH).
2.4. RT-PCR analysis
RT-PCR analysis was performed as described by Kim
and Levin (2011). Briefly, cells growing in log phase were
divided with three tubes at OD600 = 0.05 and treated with
ampicillin for 30 min or 90 min. One of the tubes was
used as an untreated control. Total RNA was extracted
as described previously (Schmitt et al., 1990; Kim and
Levin, 2011). cDNA was synthesized using Superscript
III reverse transcriptase (Invitrogen) according to the
manufacturer’s instructions and amplified by PCR
using Taq polymerase with 18S rRNA forward primer
(ACTTTTCGAATCGCATGGCC) and 18S rRNA reverse
primer (GAATCGAACCCTTATTCCCC), or FKS2
forward primer (GCAAATTGCCTACCTGGATG) and
FKS2 reverse primer (CTCTTCCAAGTAATTGTCTTG)
(Kim and Levin, 2011).
2.5. Antifungal susceptibility test
Antifungal activity against S. cerevisiae or C. albicans was
tested using the broth microdilution assay based on the
standard NCCLS document M27-A (NCCLS, 1997) as
described in Kim et al. (2004) and Shin and Kim (2016).
A stock of miconazole (10 g/L) was first serially 2-fold
diluted with or without 3 mM ampicillin and dispensed
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in duplicate into wells of a 96-well microtiter plate with
a total volume of 100 µL of RPMI 1640 medium (RPMI
tissue culture medium supplemented with glutamine;
Sigma) with 2% glucose, buffered to pH 7.0 with 0.156 M
3-N-morpholinopropanesulfonic acid (MOPS; Sigma).
S. cerevisiae or C. albicans was inoculated with 100 µL of
suspension containing 1 × 104 cells/mL. Final miconazole
concentrations ranged from 200 µg/mL to 0.2 µg/mL. The
last well was used for contamination control. MIC values of
miconazole were determined as the lowest concentration
of the compound that gave 100% inhibition of cell growth.
Tests were performed at least three times.
2.6. Cell proliferation assay
S. cerevisiae proliferation was evaluated using a cell growth
curve. S. cerevisiae was inoculated with 3 mL (OD600 =
0.1) of suspension containing various concentrations of
ampicillin (0–3 mM). After the indicated time, the cell
proliferation rates were calculated from the optical density
(OD600) readings. Experiments were performed at least
three times.
HepG2 cell proliferation was evaluated using a cellbased MTT assay (Shin and Kim, 2016). Cells were seeded
at 1 × 104 cells per well in 96-well plates and incubated
for 24 h. Cells were washed with PBS and then cultured
in DMEM containing various concentrations of ampicillin
(0–4 mM). After 48 h of incubation, the cells were
washed and MTT solution in PBS was added to a final
concentration of 0.5 mg/mL. After incubation for 3 h at 37
°C, absorbance was obtained at 520 nm using a microplate
reader (VersaMax, Molecular Devices, Sunnyvale, CA,
USA). The cell proliferation rates were calculated from the
optical density readings and represented as percentages of
those for the vehicle control.
2.7. Statistical analysis
Values are expressed as the mean ± SD. Differences between
the control and samples were evaluated using Student’s
t-test. P < 0.05 was considered statistically significant.
3. Results
3.1. Ampicillin-induced Mpk1 phosphorylation
To investigate PCK1-CWI pathway regulation in S.
cerevisiae by ampicillin, we examined the induction of
Mpk1 phosphorylation. Mpk1 phosphorylation was
increased even from the 0.5 mM treatment, and it was clear
above 2 mM ampicillin with a maximal effect at 3 mM.
However, increased Mpk1 phosphorylation was not seen
after treatment with 3 mM ampicillin in the bck1Δ deletion
strain (Figure 1A). To determine the time dependency,
we measured phospho-Mpk1 after treatment with 3 mM
ampicillin for different times. Mpk1 phosphorylation was
induced after 30 min and maximized at 90 min of ampicillin
treatment (Figure 1B). Thus, phosphorylation of Mpk1 in
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Figure 1. Ampicillin activates phosphorylation of Mpk1 in S. cerevisiae. (A) Mpk1 phosphorylation is dose-dependently stimulated by
ampicillin. Mpk1 phosphorylation was examined after treatment with various concentrations of ampicillin for 1 h in a bck1Δ or mpk1Δ
strain bearing YEp351-Mpk1-FLAG. The densitometry analysis data are expressed as fold relative to Mpk1-FLAG expression. Values are
means ± SD. Asterisks indicate significant differences (*P < 0.05, **P < 0.01) between no treatment and ampicillin treatment. (B) Time
course for Mpk1 phosphorylation by ampicillin. Mpk1 phosphorylation was examined after treatment with 3 mM ampicillin for the
indicated time (min). The densitometry analysis data are expressed as fold relative to Mpk1-FLAG expression. Values are means ± SD.
Asterisks indicate significant differences (***P < 0.001) between 0 min and each time point. (C) Mpk1 phosphorylation is induced by
ampicillin. Mpk1 phosphorylation was tested by treatment with 3 mM ampicillin, Congo red, or heat stress for 1 h. U, unstressed (RT);
CR, 50 mg/mL Congo red; HS, heat stress at 39 °C; Am, 3 mM ampicillin. The densitometry analysis data are expressed as fold relative
to Mpk1-FLAG expression. Values are means ± SD. Asterisks indicate significant differences (*P < 0.05, **P < 0.01) between U and each
stress condition. (D) FKS2 gene expression is stimulated by ampicillin. Wild-type S. cerevisiae cells were treated with 3 mM ampicillin
for the indicated time (min). Total RNA was used for RT-PCR analysis of FKS2 mRNA and 18S RNA. Whole-cell extract was used to
confirm RT-PCR product size. The densitometry analysis data are expressed as fold relative to 18S expression. Values are means ± SD.
Asterisks indicate significant differences (*P < 0.05) between 0 min and 90 min.

S. cerevisiae is dependent on the PKC1-CWI pathway and
maximal after treatment with 3 mM ampicillin for 90 min.
To assess the efficiency of ampicillin for the induction
of Mpk1 phosphorylation compared with Congo red and
heat stress, both of which induce cell wall stress (Kim
and Levin, 2011), Mpk1 phosphorylation was examined
after 1 h under each stress condition. Induction of Mpk1
phosphorylation by ampicillin was more effective than
that with Congo red, but similar to the effect of heat stress
(Figure 1C).

FKS2 gene expression is induced by activated Mpk1
in response to various cell wall stresses (Kim et al., 2008).
Therefore, we measured FKS2 gene expression after 30
min and 90 min of 3 mM ampicillin treatment and showed
that FKS2 mRNA expression was induced after 90 min of
treatment with 3 mM ampicillin (Figure 1D).
3.2. Ampicillin inhibited miconazole antifungal activity
Based on activation of Mpk1 phosphorylation by
ampicillin, we speculated that ampicillin might suppress
miconazole antifungal activity because miconazole
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3.3. Ampicillin activated ERK1/2 phosphorylation
ERK MAPKs are human homologues of Mpk1 that
participate in cell proliferation. We examined ERK1/2
phosphorylation in HepG2 cell lines (Figure 2) and
found that ampicillin induced ERK1/2 phosphorylation
with a maximum effect at 3 mM ampicillin. This result is
consistent with the induction of Mpk1 phosphorylation in
yeast. Normally, about 0.3 mM ampicillin is used in cell
culture media to prevent microbial growth. In Figure 2,
phosphorylation of ERK1/2 is seen to be increased in the
0.38 mM treatment. Even though the phosphorylation
level of ERK1/2 in 0.3 mM ampicillin was not high enough,
researchers need to consider the effect of ampicillin on
MAPK signal transduction.

inhibits ergosterol biosynthesis. In addition, the PKC1CWI pathway is related to azole resistance and Mpk1
inhibition has a synergistic effect on the antifungal activity
of miconazole (Edlind et al., 2002; LaFayette et al., 2010;
Shin and Kim, 2016). We performed a broth microdilution
assay to determine the effect of ampicillin on the MIC of
miconazole. For this, we used 3 mM ampicillin and the
control was treated with the same volume of vehicle. After
ampicillin treatment for 24 h and 48 h, the MIC values of
miconazole against C. albicans increased from 1.56 to 25
µg/mL and from 3.125 to 25 µg/mL after incubation with
ampicillin, respectively. MIC values of miconazole against
S. cerevisiae also increased from 3.125 to 6.25 µg/mL after
24 or 48 h of incubation in the presence of ampicillin
(Table).

Table. Ampicillin suppresses miconazole antifungal activity. MIC, minimum inhibitory concentration
(µg/mL).
MIC without ampicillin

MIC with ampicillin

24 h

48 h

24 h

48 h

Candida albicans

1.56

3.125

25

25

Saccharomyces cerevisiae

3.125

3.125

6.25

6.25

Ampicillin [mM]
0

0.38

0.75

1.5

3
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ERK1/2

F o ld o f in d u c tio n

5

**

***
*

1.5

3

4
3

*

2
1
0

0

0.38

0.75

Ampicillin (mM)

Figure 2. Ampicillin activates ERK1/2 phosphorylation in HepG2 cells.
HepG2 cells were subjected to western blotting with antibodies specific
for ERK1/2 or phosphorylated ERK1/2. The densitometry analysis data
are expressed as fold relative to ERK1/2 expression. Values are means ±
SD. Asterisks indicate significant differences (*P < 0.05, **P < 0.01, ***P <
0.001) between no treatment and ampicillin treatment.
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4. Discussion
Ampicillin has been widely used to eliminate bacterial
infection because of its potent antibacterial activity
and low level of side effects on animal cells. When we
tried to remove bacterial contamination to study Mpk1
activation in yeast, we observed unusual activation of
Mpk1 phosphorylation in the absence of any stress. The
finding that ampicillin appeared to activate MAPK was a
surprise because it has been used as an antibiotic for a long
time. We therefore performed this study to confirm that
ampicillin actually activates Mpk1 phosphorylation and
investigate the underlying mechanism.
We found that ampicillin maximally activated Mpk1
phosphorylation at concentration of 3 mM for 90 min.
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Under these conditions, ampicillin also activated FKS2
gene expression. Induction of FKS2 mRNA has been
proposed to decrease miconazole antifungal activity. These
results are consistent, as the azole increased FKS2 gene
expression and the PKC1 pathway is related with azole
resistance. Moreover, miconazole combined with MAPK
inhibitors showed synergistic antifungal activity. Together
these data indicate that ampicillin activated the PKC1CWI pathway.
Ampicillin did not influence cell growth based on the
MIC value (>200 µg/mL for S. cerevisiae and C. albicans)
and cell growth analysis. Because Mpk1 phosphorylation
is dependent on the PKC1-CWI pathway, we wondered
whether ampicillin affects cell wall integrity, but we did
not find any differences between treated and untreated
cells in microscopic analysis with respect to cell lysis, cell
size, and cell shape in log phase (data not shown). ERK1/2
phosphorylation was also induced by treatment with
ampicillin but did not influence cell viability of HepG2
cells. These results suggest that activation of MAPK (Mpk1
and ERK1/2) phosphorylation is not related to cell wall
stress, but rather occurs through another mechanism.
7
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3.4. Ampicillin did not influence cell viability
The finding that ampicillin activated Mpk1 and ERK1/2
phosphorylation suggested that ampicillin might
influence cell viability or growth. The PKC1-CWI pathway
participates in cell wall integrity and ERK1/2 participates
in cell proliferation. If treatment with ampicillin reduces
cell wall integrity, there may be a delay in cell growth, or
the induction of MAPK phosphorylation might increase
cell viability. We tested S. cerevisiae cell growth and HepG2
cell viability in the presence of various concentrations of
ampicillin, but we did not see any growth effects (Figure
3A) in S. cerevisiae or any effect on HepG2 cell viability
by the MTT assay (Figure 3B). These results suggested
that ampicillin increases MAPK phosphorylation without
affecting cell viability or growth.
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transcription of numerous genes implicated in cell cycle,
cell survival, and cell motility. ERK1/2 phosphorylation is
subject to extensive negative feedback regulation, which
allows for fine-tuning of pathway activation and output.
For example, the Gα13-mediated pathway is regulated by
ERK1/2 activation. During the regulation, even though
the extent of ERK1/2 activation was very low and barely
detectable, Gα13-dependent activation of a phosphatase
was responsible for these different levels of ERK regulation
(Mariggio et al., 2006). Therefore, even though the
phosphorylation level of ERK1/2 in 0.3 mM ampicillin was
not high enough, researchers need to consider the effect of
ampicillin on MAPK signal transduction.
Interestingly, ERK participates in some immune
response mechanisms; ERK activates expression of
cytokines such as IL-10 (Lucas et al., 2005) and blocks

T-cell apoptosis (Gu et al., 2013), and fungal infection
blocks the expression of proinflammatory transcripts
and interleukin proteins through ERK1/2 (Zanello et al.,
2011). This suggests that ampicillin-induced activation of
ERK phosphorylation is related to activation or induced
expression of cytokines within macrophages or other
immune response cells. Our future goal is to identify
whether ampicillin can activate immune response cells
and induce cytokine expression.
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